For example, a current gene therapy strategy for late-onset Parkinson disease (PD, OMIM # 168600) uses administration of L-DOPA, which is converted to dopamine by the enzyme Aromatic L-Amino Acid Decarboxylase (AADC). The gene discussed is DDC; the disease is Parkinson disease.